Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Washington Research Foundation

WRF was founded in 1981 to assist universities and other nonprofit research institutions in the state of Washington with commercialization of their technologies and to provide support, through gifts and grants, for scholarship and research. WRF is an independent private foundation whose operational revenue comes from retained funds from licensing and investing activities.
WRF has given gifts and licensing disbursements to the University of Washington totaling more than $150,000,000. The aggregate amount is comprised of returns from licensing, gifts, and realized gains on transferred equity. WRF has benefited Washington state research institutions by licensing a variety of technologies to industry, including the basis for hepatitis B virus vaccine, blood clotting factors, recombinant insulin, and wireless technology supporting the “Bluetooth” protocol.
The gifts from WRF have supported the creation of over 100 endowments for chairs, professorships, research fellowships and graduate stipends in science, medicine and engineering. Educational programs created and supported by WRF include the Center for Technology Entrepreneurship (UW Business School) and the Program for Technology Commercialization (UW Bioengineering). WRF was a founding supporter of technology “gap” funding programs at the University of Washington, the Fred Hutchinson Cancer Research Center, and Washington State University.


Contact Details:
2815 Eastlake Ave. E.Suite 300
Seattle
Washington
98102
United States of America
Tel: (206) 336-5600
Fax:(206) 336-5615
Email:morgan@wrfcapital.com
WWW:

www.wrfseattle.org/




Loading...

BioNews Results for Washington Research Foundation:

DC HIV Study: Can Intense Treatment Prevent Spread?
Medical News Today:  Nov 16 2009 9:05AM Matching: washington research foundation
Eighth-grader walks for cure for Type 1 diabetes
Ramona Sentinel:  Nov 14 2009 11:30PM Matching: washington research foundation
Drug firm Emergent to expand
Washington Post:  Nov 14 2009 3:36AM Matching: washington research foundation
Md. drug firm buys site for R&D, testing
Washington Post:  Nov 14 2009 3:08AM Matching: washington research foundation
Yoghurt story 'hard to swallow'
Nursing Times:  Nov 13 2009 3:42PM Matching: washington research foundation
Promote your company here: BioNewsCast - Press Release Distribution

View more Washington Research Foundation news.

Washington Research Foundation Patents:

US Patent No.Title
5601989 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy
5773230 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy
5817755 Synthetic peptide analogs of cross-linked N-telopeptides of type I collagen
5821055 Chlamydia major outer membrane protein
5834221 Assay for type I collagen carboxy-terminal telopeptide analytes

View more Washington Research Foundation patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 354 times since April 2007, the link to the organisation's website has been followed 58 times

Recent Search Terms used to find this page: washington research foundation logo | Washington Research Foundation | UW bioengineering | .

Search for more companies in Seattle

Search for more companies in Washington



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Washington Research Foundation

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.